Status:
UNKNOWN
Colorectal Cancer Screening Validation Study
Lead Sponsor:
IntelliGeneScan, Inc.
Collaborating Sponsors:
BiotechNiks / Molecular Medicine Research Institute
Conditions:
Colorectal Cancer Screening
Eligibility:
All Genders
50+ years
Brief Summary
The purpose of this study is to evaluate the gene expression patterns from colorectal mucosal cells collected through the use of a standard anoscope and cytology brush. Patients will include those sch...
Eligibility Criteria
Inclusion
- willing to provide informed consent
- greater than or equal to 50 years of age
- patient is scheduled for routine colonoscopy procedure or colorectal cancer surgery
- subject is willing to provide colorectal mucosal sample for gene expression testing
Exclusion
- recent radiation or treatment for gynecologic, prostate or rectal cancer
- recent surgery for anal rectal disease
- polys, family or self history of cancer (control group only)
- GI disease
- any mucosal disease or systemic condition that may confound the scientific interpretation of the gene expression results
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2009
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT00720993
Start Date
August 1 2008
End Date
May 1 2009
Last Update
April 23 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905